MedTrace Logo

Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers

NCT03254901 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2017-08-21

No results posted yet for this study

Summary

Viral hepatitis is a global health problem affecting hundred millions of people worldwide and considered the main cause of liver cirrhosis, hepatocellular carcinoma and liver transplantation in developing countries.

Conditions

  • Hepatitis C

Interventions

OTHER

Screening test by Oraquick test

The OraQuick assay uses an indirect immunoassay method to detect hepatitis C antibodies in oral fluid or blood

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-06-01
Completion
2018-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03254901 on ClinicalTrials.gov